ARTICLE | Company News
ImmunID, Scancell deal
September 21, 2015 7:00 AM UTC
The companies will use ImmunID’s ImmunTraCkeR test to predict which patients will respond to Scancell’s SCIB1, a cancer vaccine comprising the melanoma antigen tyrosinase-related protein 2 ( TRP-2;...